N Esfandiari1, S Ghosh, C M M Prado, L Martin, V Mazurak, V E Baracos. 1. Dr. Vickie E Baracos, Division of Palliative Care Medicine, Department of Oncology, University of Alberta, Cross Cancer Institute, 11560 University Avenue, Edmonton, Alberta, Canada, T6G 1Z2, Telephone: +1 (780) 432-8232 Fax: +1 (780) 432-8425 Email: vickie.baracos@ualberta.ca.
Abstract
BACKGROUND: Cancer cachexia is characterized by skeletal muscle loss. A feature of muscle wasting, reduction in the mean muscle attenuation from computed tomography images is believed to reflect pathological infiltration of fat into muscle. It is a reported prognostic indicator in cancer patients. OBJECTIVES: To develop an explanatory multivariate model of muscle attenuation of cancer patients incorporating age, sex, disease characteristics, body composition. Time to death ≤92 days was included in the model as the demarcation of end-stage disease. DESIGN: Multivariate general linear model regression analysis of total mean muscle attenuation and change in muscle attenuation. SETTING: Regional cancer center (Alberta, Canada). PARTICIPANTS: Patients with gastrointestinal and respiratory tract cancers (mean age 64±11 years, 44% female). MEASUREMENTS: Total adipose tissue and skeletal muscle cross sectional area, and mean muscle attenuation at the 3rd lumbar vertebra were assessed from baseline computed tomography (n=1719), and a subset with repeated measures (n=246 patients with a total of 871 images). RESULTS: At baseline, muscle attenuation associated with total skeletal muscle (β 0.09; 95% CI 0.07 to 0.11; p<0.001) and adipose tissue (β -0.032; 95% CI -0.035 to -0.029; p<0.001) cross sectional areas, age (β -0.28; 95% CI -0.32 to -0.24; p<0.001), time to death ≤92 days (β -1.9; 95% CI -3.1 to -0.7; p=0.003) and male sex (β -2.3; 95% CI -3.5 to -1.1; p<0.001). Change in muscle attenuation over time associated with total adipose tissue cross sectional area (β -0.008; 95% CI -0.012 to -0.004; p<0.001) and time to death ≤92 days (β -1.6; 95% CI -3.0 to -0.2; p=0.03). CONCLUSIONS: The radiation attenuation of skeletal muscle is lowest in individuals who are older, less muscular, have a higher fat mass and are within 92 days of death. Men had lower muscle attenuation than women when controlled for other variables.
BACKGROUND:Cancer cachexia is characterized by skeletal muscle loss. A feature of muscle wasting, reduction in the mean muscle attenuation from computed tomography images is believed to reflect pathological infiltration of fat into muscle. It is a reported prognostic indicator in cancerpatients. OBJECTIVES: To develop an explanatory multivariate model of muscle attenuation of cancerpatients incorporating age, sex, disease characteristics, body composition. Time to death ≤92 days was included in the model as the demarcation of end-stage disease. DESIGN: Multivariate general linear model regression analysis of total mean muscle attenuation and change in muscle attenuation. SETTING: Regional cancer center (Alberta, Canada). PARTICIPANTS: Patients with gastrointestinal and respiratory tract cancers (mean age 64±11 years, 44% female). MEASUREMENTS: Total adipose tissue and skeletal muscle cross sectional area, and mean muscle attenuation at the 3rd lumbar vertebra were assessed from baseline computed tomography (n=1719), and a subset with repeated measures (n=246 patients with a total of 871 images). RESULTS: At baseline, muscle attenuation associated with total skeletal muscle (β 0.09; 95% CI 0.07 to 0.11; p<0.001) and adipose tissue (β -0.032; 95% CI -0.035 to -0.029; p<0.001) cross sectional areas, age (β -0.28; 95% CI -0.32 to -0.24; p<0.001), time to death ≤92 days (β -1.9; 95% CI -3.1 to -0.7; p=0.003) and male sex (β -2.3; 95% CI -3.5 to -1.1; p<0.001). Change in muscle attenuation over time associated with total adipose tissue cross sectional area (β -0.008; 95% CI -0.012 to -0.004; p<0.001) and time to death ≤92 days (β -1.6; 95% CI -3.0 to -0.2; p=0.03). CONCLUSIONS: The radiation attenuation of skeletal muscle is lowest in individuals who are older, less muscular, have a higher fat mass and are within 92 days of death. Men had lower muscle attenuation than women when controlled for other variables.
Authors: Jingjie Xiao; Bette J Caan; Elizabeth M Cespedes Feliciano; Jeffrey A Meyerhardt; Candyce H Kroenke; Vickie E Baracos; Erin Weltzien; Marilyn L Kwan; Stacey E Alexeeff; Adrienne L Castillo; Carla M Prado Journal: Am J Clin Nutr Date: 2019-03-01 Impact factor: 7.045
Authors: Jingjie Xiao; Bette J Caan; Erin Weltzien; Elizabeth M Cespedes Feliciano; Candyce H Kroenke; Jeffrey A Meyerhardt; Vickie E Baracos; Marilyn L Kwan; Adrienne L Castillo; Carla M Prado Journal: J Cachexia Sarcopenia Muscle Date: 2018-04-19 Impact factor: 12.910
Authors: Amritpal S Bhullar; Ana Anoveros-Barrera; Abha Dunichand-Hoedl; Karen Martins; David Bigam; Rachel G Khadaroo; Todd McMullen; Oliver F Bathe; Charles T Putman; Michael T Clandinin; Vickie E Baracos; Vera C Mazurak Journal: J Cachexia Sarcopenia Muscle Date: 2020-01-27 Impact factor: 12.910
Authors: Ashok Narasimhan; Xiaoling Zhong; Ernie P Au; Eugene P Ceppa; Atilla Nakeeb; Michael G House; Nicholas J Zyromski; C Max Schmidt; Katheryn N H Schloss; Daniel E I Schloss; Yunlong Liu; Guanglong Jiang; Bradley A Hancock; Milan Radovich; Joshua K Kays; Safi Shahda; Marion E Couch; Leonidas G Koniaris; Teresa A Zimmers Journal: Cancers (Basel) Date: 2021-04-20 Impact factor: 6.639
Authors: Ashok Narasimhan; Safi Shahda; Joshua K Kays; Susan M Perkins; Lijun Cheng; Katheryn N H Schloss; Daniel E I Schloss; Leonidas G Koniaris; Teresa A Zimmers Journal: Cancers (Basel) Date: 2020-12-15 Impact factor: 6.639